Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Kong

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapyXu-Wei Cai, Lu-Ying Xu, Li Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and MichiganLujun Zhao, Luhua Wang, Wei Ji, et al.
Plos One|September 22, 2017
Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapySusannah G Ellsworth, Bryan M Rabatic, Jie Chen, et al.
Neoplasia (New York, N.Y.)|March 20, 2023
Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cellsHehuan Sui, Sisi Xiao, Suping Jiang, et al.
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intentRichard M Gewanter, Kenneth E Rosenzweig, Joe Yujiao Chang, et al.
Journal of the American College of Radiology : JACR|January 31, 2009
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Benjamin Movsas, Jeff Bradley, et al.
Medicine|January 28, 2022
Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinomaRen Ji, Kelvin K Ng, Wenqi Chen, et al.
American Journal of Clinical Oncology|September 28, 2011
ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancerRoy H Decker, Corey J Langer, Kenneth E Rosenzweig, et al.
Journal of Nanobiotechnology|December 30, 2025
CXCR4-engineered fibroblast membrane nanovesicles for Photothermal-enhanced ferroptotic therapy through chemokine-navigated tumor homingLu Bai, Ya-Nan Tan, Li-Fen Zhang, et al.
Journal of Thoracic Imaging|November 3, 2010
ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinomaJames G Ravenel, Tan-Lucien H Mohammed, Benjamin Movsas, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapyXu-Wei Cai, Lu-Ying Xu, Li Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and MichiganLujun Zhao, Luhua Wang, Wei Ji, et al.
Plos One|September 22, 2017
Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapySusannah G Ellsworth, Bryan M Rabatic, Jie Chen, et al.
Neoplasia (New York, N.Y.)|March 20, 2023
Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cellsHehuan Sui, Sisi Xiao, Suping Jiang, et al.
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intentRichard M Gewanter, Kenneth E Rosenzweig, Joe Yujiao Chang, et al.
Journal of the American College of Radiology : JACR|January 31, 2009
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Benjamin Movsas, Jeff Bradley, et al.
Medicine|January 28, 2022
Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinomaRen Ji, Kelvin K Ng, Wenqi Chen, et al.
American Journal of Clinical Oncology|September 28, 2011
ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancerRoy H Decker, Corey J Langer, Kenneth E Rosenzweig, et al.
Journal of Nanobiotechnology|December 30, 2025
CXCR4-engineered fibroblast membrane nanovesicles for Photothermal-enhanced ferroptotic therapy through chemokine-navigated tumor homingLu Bai, Ya-Nan Tan, Li-Fen Zhang, et al.
Journal of Thoracic Imaging|November 3, 2010
ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinomaJames G Ravenel, Tan-Lucien H Mohammed, Benjamin Movsas, et al.
Pageof 8